VICTOR GONZALEZ to Diabetic Retinopathy
This is a "connection" page, showing publications VICTOR GONZALEZ has written about Diabetic Retinopathy.
Connection Strength
1.942
-
Three-Year Safety and Efficacy of the 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: The PALADIN Study. Ophthalmology. 2022 06; 129(6):605-613.
Score: 0.660
-
Panretinal Photocoagulation for Diabetic Retinopathy in the RIDE and RISE Trials: Not "1 and Done". Ophthalmology. 2021 10; 128(10):1448-1457.
Score: 0.558
-
Early and Long-Term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data. Am J Ophthalmol. 2016 Dec; 172:72-79.
Score: 0.456
-
One-Time Intravitreal Injection of KVD001, a Plasma Kallikrein Inhibitor, in Patients with Central-Involved Diabetic Macular Edema and Reduced Vision: An Open-Label Phase 1B Study. Ophthalmol Retina. 2019 12; 3(12):1107-1109.
Score: 0.139
-
Early Response to Anti-Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes With Diabetic Macular Edema in Protocol T. Am J Ophthalmol. 2018 11; 195:93-100.
Score: 0.130